ÐÓ°ÉÖ±²¥

ENZAMET shows promise as prostate cancer treatment

The results from the clinical trial of ENZAMET, co-chaired by Professor Christopher Sweeney, Director of the South ÐÓ°ÉÖ±²¥n immunoGENomics Cancer Institute (SAiGENCI) that operates within the ÐÓ°ÉÖ±²¥ of Adelaide, have been published today in .

[Read more about ENZAMET shows promise as prostate cancer treatment ]